Profile
John Z.
Sullivan-Bólyai worked as a Director in Infectious Disease Clinical Research at Merck & Co., Inc. from 2004 to 2015.
Prior to that, he was a Director of Clinical Science at Hoffmann-La Roche, Inc. from 1989 to 1996, and a Medical Director of Metabolic & Immune Therapy at EMD Serono, Inc. in 1996-1997.
He also worked as a Senior Medical Director at Biomeasure, Inc. from 1997 to 2005.
He held the position of Chief Medical Officer at Hepion Pharmaceuticals, Inc. from 2015 to 2017.
He also worked as an Assistant Vice President of Research & Development at Bausch Health Americas, Inc., Vice President of Clinical Research at Idenix Pharmaceuticals LLC, and Vice President of Clinical Affairs at Anadys Pharmaceuticals, Inc. Dr. Sullivan-Bólyai received his undergraduate degree from Dartmouth College and his graduate and doctorate degrees from the University of Washington.
Former positions of John Z. Sullivan-Bólyai
| Companies | Position | End |
|---|---|---|
| HEPION PHARMACEUTICALS, INC. | Chief Tech/Sci/R&D Officer | 2017-12-28 |
| MERCK & CO., INC. | Corporate Officer/Principal | 2014-12-31 |
Biomeasure, Inc.
 Biomeasure, Inc. Pharmaceuticals: MajorHealth Technology Part of Ipsen SA, Biomeasure, Inc. researches, develops, and manufactures peptides and toxins for treating various conditions. The private company is based in Milford, MA. The company was founded by Jacques Pierre Moreau. | Chief Tech/Sci/R&D Officer | 2004-12-31 |
EMD Serono, Inc.
 EMD Serono, Inc. Pharmaceuticals: MajorHealth Technology EMD Serono, Inc. operates as a biopharmaceutical firm. The firm develops recombinant prescription medicines. Its therapies include neurology and immunology, metabolic endocrinology, fertility, and oncology. The company was founded in 1971 and is headquartered in Rockland, MA. | Corporate Officer/Principal | 1996-12-31 |
Hoffmann-La Roche, Inc.
 Hoffmann-La Roche, Inc. BiotechnologyHealth Technology Hoffmann-La Roche, Inc. manufactures pharmaceutical drugs. Its products include influenza fighter Tamiflu, controversial acne medication Accutane, HIV inhibitor Fuzeon, obesity drug Xenical, and hepatitis C therapy Pegasys. The company was founded in 1896 Roche and is headquartered in Nutley, NJ. | Chief Tech/Sci/R&D Officer | 1995-12-31 |
Training of John Z. Sullivan-Bólyai
| Dartmouth College | Undergraduate Degree |
| University of Washington | Doctorate Degree |
Experiences
Positions held
Active
Inactive
Listed companies
Private companies
Connections
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
| Listed companies | 2 |
|---|---|
| HEPION PHARMACEUTICALS, INC. | Health Technology |
| MERCK & CO., INC. | Health Technology |
| Private companies | 6 |
|---|---|
Anadys Pharmaceuticals, Inc.
 Anadys Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Anadys Pharmaceuticals, Inc. develops and manufactures novel small molecule medicines. It engages in developing novel medicines in the areas of hepatitis C and oncology. The firm develops ANA598, a direct-acting antiviral for the treatment of hepatitis C. The company was founded by Stelios B. Papadopoulos and Kleanthis G. Xanthopoulos in 1992 and is headquartered in Little Falls, NJ. | Health Technology |
Bausch Health Americas, Inc.
 Bausch Health Americas, Inc. Pharmaceuticals: MajorHealth Technology Bausch Health Americas, Inc. manufactures and distributes pharmaceutical products. The company was founded on November 29, 2011 and is headquartered in Bridgewater, NJ. | Health Technology |
Biomeasure, Inc.
Biomeasure, Inc. Pharmaceuticals: MajorHealth Technology Part of Ipsen SA, Biomeasure, Inc. researches, develops, and manufactures peptides and toxins for treating various conditions. The private company is based in Milford, MA. The company was founded by Jacques Pierre Moreau. | Health Technology |
EMD Serono, Inc.
EMD Serono, Inc. Pharmaceuticals: MajorHealth Technology EMD Serono, Inc. operates as a biopharmaceutical firm. The firm develops recombinant prescription medicines. Its therapies include neurology and immunology, metabolic endocrinology, fertility, and oncology. The company was founded in 1971 and is headquartered in Rockland, MA. | Health Technology |
Hoffmann-La Roche, Inc.
Hoffmann-La Roche, Inc. BiotechnologyHealth Technology Hoffmann-La Roche, Inc. manufactures pharmaceutical drugs. Its products include influenza fighter Tamiflu, controversial acne medication Accutane, HIV inhibitor Fuzeon, obesity drug Xenical, and hepatitis C therapy Pegasys. The company was founded in 1896 Roche and is headquartered in Nutley, NJ. | Health Technology |
Idenix Pharmaceuticals LLC
 Idenix Pharmaceuticals LLC Pharmaceuticals: MajorHealth Technology Idenix Pharmaceuticals LLC is a biopharmaceutical company, which is engaged in the discovery and development of drugs for the treatment of human viral diseases with operations in the United States and France. Currently, its primary research and development focus is on the treatment of patients with hepatitis C virus, or HCV, using nucleotide polymerase inhibitors and NS5A inhibitors. Idenix Pharmaceuticals was founded by Jean-Pierre Sommadossi and Raymond F. Schinazi in May 1998 and is headquartered in Cambridge, MA. | Health Technology |
- Stock Market
- Insiders
- John Z. Sullivan-Bólyai
